Zeranol is a non-steroidal estrogen agonist. It is a mycotoxin, derived from fungi in the Fusarium family, and may be found as a contaminant in fungus-infected crops. It is 3-4x more potent as an estrogen agonist than the related compound zearalenone.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prasterone | The risk or severity of adverse effects can be increased when Prasterone is combined with Zeranol. |
| Exemestane | The therapeutic efficacy of Exemestane can be decreased when used in combination with Zeranol. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Zeranol. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Zeranol. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Zeranol. |
| Lenalidomide | Zeranol may increase the thrombogenic activities of Lenalidomide. |
| Ospemifene | The risk or severity of adverse effects can be increased when Zeranol is combined with Ospemifene. |
| Ropinirole | Zeranol may increase the excretion rate of Ropinirole which could result in a lower serum level and potentially a reduction in efficacy. |
| Thalidomide | Zeranol may increase the thrombogenic activities of Thalidomide. |
| Cetuximab | Zeranol may increase the thrombogenic activities of Cetuximab. |
| Human immunoglobulin G | Zeranol may increase the thrombogenic activities of Human immunoglobulin G. |
| Omalizumab | Zeranol may increase the thrombogenic activities of Omalizumab. |
| Adalimumab | Zeranol may increase the thrombogenic activities of Adalimumab. |
| Gemtuzumab ozogamicin | Zeranol may increase the thrombogenic activities of Gemtuzumab ozogamicin. |
| Indium In-111 satumomab pendetide | Zeranol may increase the thrombogenic activities of Indium In-111 satumomab pendetide. |
| Infliximab | Zeranol may increase the thrombogenic activities of Infliximab. |
| Trastuzumab | Zeranol may increase the thrombogenic activities of Trastuzumab. |
| Rituximab | Zeranol may increase the thrombogenic activities of Rituximab. |
| Basiliximab | Zeranol may increase the thrombogenic activities of Basiliximab. |
| Muromonab | Zeranol may increase the thrombogenic activities of Muromonab. |
| Digoxin Immune Fab (Ovine) | Zeranol may increase the thrombogenic activities of Digoxin Immune Fab (Ovine). |
| Ibritumomab tiuxetan | Zeranol may increase the thrombogenic activities of Ibritumomab tiuxetan. |
| Tositumomab | Zeranol may increase the thrombogenic activities of Tositumomab. |
| Alemtuzumab | Zeranol may increase the thrombogenic activities of Alemtuzumab. |
| Capromab pendetide | Zeranol may increase the thrombogenic activities of Capromab pendetide. |
| Efalizumab | Zeranol may increase the thrombogenic activities of Efalizumab. |
| Antithymocyte immunoglobulin (rabbit) | Zeranol may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit). |
| Natalizumab | Zeranol may increase the thrombogenic activities of Natalizumab. |
| Palivizumab | Zeranol may increase the thrombogenic activities of Palivizumab. |
| Daclizumab | Zeranol may increase the thrombogenic activities of Daclizumab. |
| Bevacizumab | Zeranol may increase the thrombogenic activities of Bevacizumab. |
| Technetium Tc-99m arcitumomab | Zeranol may increase the thrombogenic activities of Technetium Tc-99m arcitumomab. |
| Eculizumab | Zeranol may increase the thrombogenic activities of Eculizumab. |
| Panitumumab | Zeranol may increase the thrombogenic activities of Panitumumab. |
| Ranibizumab | Zeranol may increase the thrombogenic activities of Ranibizumab. |
| Galiximab | Zeranol may increase the thrombogenic activities of Galiximab. |
| Pexelizumab | Zeranol may increase the thrombogenic activities of Pexelizumab. |
| Afelimomab | Zeranol may increase the thrombogenic activities of Afelimomab. |
| Epratuzumab | Zeranol may increase the thrombogenic activities of Epratuzumab. |
| Bectumomab | Zeranol may increase the thrombogenic activities of Bectumomab. |
| Oregovomab | Zeranol may increase the thrombogenic activities of Oregovomab. |
| IGN311 | Zeranol may increase the thrombogenic activities of IGN311. |
| Adecatumumab | Zeranol may increase the thrombogenic activities of Adecatumumab. |
| Labetuzumab | Zeranol may increase the thrombogenic activities of Labetuzumab. |
| Matuzumab | Zeranol may increase the thrombogenic activities of Matuzumab. |
| Fontolizumab | Zeranol may increase the thrombogenic activities of Fontolizumab. |
| Bavituximab | Zeranol may increase the thrombogenic activities of Bavituximab. |
| CR002 | Zeranol may increase the thrombogenic activities of CR002. |
| Rozrolimupab | Zeranol may increase the thrombogenic activities of Rozrolimupab. |
| Girentuximab | Zeranol may increase the thrombogenic activities of Girentuximab. |
| Obiltoxaximab | Zeranol may increase the thrombogenic activities of Obiltoxaximab. |
| XTL-001 | Zeranol may increase the thrombogenic activities of XTL-001. |
| NAV 1800 | Zeranol may increase the thrombogenic activities of NAV 1800. |
| Briakinumab | Zeranol may increase the thrombogenic activities of Briakinumab. |
| Otelixizumab | Zeranol may increase the thrombogenic activities of Otelixizumab. |
| AMG 108 | Zeranol may increase the thrombogenic activities of AMG 108. |
| Iratumumab | Zeranol may increase the thrombogenic activities of Iratumumab. |
| Enokizumab | Zeranol may increase the thrombogenic activities of Enokizumab. |
| Ramucirumab | Zeranol may increase the thrombogenic activities of Ramucirumab. |
| Farletuzumab | Zeranol may increase the thrombogenic activities of Farletuzumab. |
| Veltuzumab | Zeranol may increase the thrombogenic activities of Veltuzumab. |
| Ustekinumab | Zeranol may increase the thrombogenic activities of Ustekinumab. |
| Trastuzumab emtansine | Zeranol may increase the thrombogenic activities of Trastuzumab emtansine. |
| PRO-542 | Zeranol may increase the thrombogenic activities of PRO-542. |
| TNX-901 | Zeranol may increase the thrombogenic activities of TNX-901. |
| Inotuzumab ozogamicin | Zeranol may increase the thrombogenic activities of Inotuzumab ozogamicin. |
| RI 624 | Zeranol may increase the thrombogenic activities of RI 624. |
| Stamulumab | Zeranol may increase the thrombogenic activities of MYO-029. |
| CT-011 | Zeranol may increase the thrombogenic activities of CT-011. |
| Leronlimab | Zeranol may increase the thrombogenic activities of Leronlimab. |
| Glembatumumab vedotin | Zeranol may increase the thrombogenic activities of Glembatumumab vedotin. |
| Olaratumab | Zeranol may increase the thrombogenic activities of Olaratumab. |
| IPH 2101 | Zeranol may increase the thrombogenic activities of IPH 2101. |
| TB-402 | Zeranol may increase the thrombogenic activities of TB-402. |
| Caplacizumab | Zeranol may increase the thrombogenic activities of Caplacizumab. |
| IMC-1C11 | Zeranol may increase the thrombogenic activities of IMC-1C11. |
| Eldelumab | Zeranol may increase the thrombogenic activities of Eldelumab. |
| Lumiliximab | Zeranol may increase the thrombogenic activities of Lumiliximab. |
| Canakinumab | Zeranol may increase the thrombogenic activities of Canakinumab. |
| Ipilimumab | Zeranol may increase the thrombogenic activities of Ipilimumab. |
| Nimotuzumab | Zeranol may increase the thrombogenic activities of Nimotuzumab. |
| Clenoliximab | Zeranol may increase the thrombogenic activities of Clenoliximab. |
| Tocilizumab | Zeranol may increase the thrombogenic activities of Tocilizumab. |
| BIIB015 | Zeranol may increase the thrombogenic activities of BIIB015. |
| Sonepcizumab | Zeranol may increase the thrombogenic activities of Sonepcizumab. |
| Motavizumab | Zeranol may increase the thrombogenic activities of Motavizumab. |
| Elotuzumab | Zeranol may increase the thrombogenic activities of Elotuzumab. |
| AVE9633 | Zeranol may increase the thrombogenic activities of AVE9633. |
| Carotuximab | Zeranol may increase the thrombogenic activities of Carotuximab. |
| XmAb 2513 | Zeranol may increase the thrombogenic activities of XmAb 2513. |
| Coltuximab ravtansine | Zeranol may increase the thrombogenic activities of Coltuximab ravtansine. |
| Lucatumumab | Zeranol may increase the thrombogenic activities of Lucatumumab. |
| Pertuzumab | Zeranol may increase the thrombogenic activities of Pertuzumab. |
| Siplizumab | Zeranol may increase the thrombogenic activities of Siplizumab. |
| Apolizumab | Zeranol may increase the thrombogenic activities of Apolizumab. |
| Sibrotuzumab | Zeranol may increase the thrombogenic activities of Sibrotuzumab. |
| Bivatuzumab | Zeranol may increase the thrombogenic activities of Bivatuzumab. |
| Lerdelimumab | Zeranol may increase the thrombogenic activities of Lerdelimumab. |
| Lexatumumab | Zeranol may increase the thrombogenic activities of Lexatumumab. |
| Reslizumab | Zeranol may increase the thrombogenic activities of Reslizumab. |